Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 2,799 full-time employees. The firm is engaged in the manufacture, sale and supply of pharmaceuticals and related products, and the operation of over-the-counter drug (OTC) business. The company is also engaged in the manufacture and sale of drugs in the United States, Brazil, Vietnam, and Indonesia, the development work in Europe, the drug marketing and sales in China and Hong Kong. The company is also engaged in the urban cable television broadcasting business, Internet connection service business, non-life insurance agency business, advertising agency business and the purchase, manufacture and sale of packing materials.
根据最新的财务报表(Form-10K),Hisamitsu Pharmaceutical Co Inc 的总资产为 $343,068,净利润为 $21,758
HTSUF 的关键财务比率是什么?
Hisamitsu Pharmaceutical Co Inc 的流动比率是 5.17,净利 margin 为 13.94,每股销售为 $2,116.23。
Hisamitsu Pharmaceutical Co Inc 的收入按细分市场或地理位置如何划分?
Hisamitsu Pharmaceutical Co Inc 最大收入来源是 Pharmaceuticals,在最近的收益报告中收入为 152,654,000,000。就地区而言, Japan 是 Hisamitsu Pharmaceutical Co Inc 的主要市场,收入为 82,364,000,000。
Hisamitsu Pharmaceutical Co Inc 是否盈利?
是的,根据最新的财务报表,Hisamitsu Pharmaceutical Co Inc 的净利润为 $21,758